Search | New Scientist

Skip to content

CRISPR-Cas9 gene-editing complex

Calm down – China is not racing ahead with human CRISPR trials

25 January 2018

Despite treating 86 people since 2015, China's approach to CRISPR genome-editing in humans is basic and risky

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up